On 29 June this year the first Early Phase Trial Oncology in Poland was opened in the Maria Skłodowska-Curie Institute of Oncology in Warsaw. During the scientific session, Aleksandra Stańczak, MD – leader of the Oncology Research group – presented the following project: Celonko – an innovative anti-FGFR therapy for patients with urinary bladder, lung andRead more »
Celon Pharma S.A. was awarded in the category of companies with revenues ranging from PLN 50 to 250 million and was placed 10th in the entire ranking in the Mazowieckie voivodship. Forbes Diamonds are awarded to the most dynamically developing companies in Poland. The award was accepted on behalf of the company by Iwona Giedronowicz,Read more »
On 19 June this year, Maciej Wieczorek was invited by the Industrial Development Agency to participate in a meeting entitled: Quo vadis medicine. The pharmaceutical market and perspectives for its development. During the discussion panel attended by representatives of pharmaceutical companies, trade unions and VC funds, effective instruments for financing innovation in pharmacy and theRead more »
A meeting of Celon Pharma S.A. with its institutional and individual investors took place on 15 May this year. We encourage you to see the video coverage of that meeting:
We encourage you to read Celon Pharma S.A.’s Yearly Report for 2016.
Celon Pharma S.A. received an award during the Business Sharks 2016 Gala in the category “Debut of the Year 2016”. The award was accepted on behalf of the company by Iwona Giedronowicz, CFO, Member of the Board at Celon Pharma S.A. Business Sharks are awards given by “investorzy.tv”, presented to entrepreneurs and representatives of theRead more »
Celon Pharma S.A. was presented with another award given to leaders of the capital market – Stock Exchange Summary of the Year 2016. The company was awarded the Bull statuette in the category: Award for the highest value of the initial public offering in 2016. The award was accepted on behalf of the company byRead more »
27 February 2017 Celon Pharma S.A. participated in a conference organised by the Centre of Preclinical Research and Technology which took place in the Educational Centre of the Medical University of Warsaw. Jerzy Pieczykolan, PhD, Head of the Department of Preclinical Trials at the R&D Centre of the Company presented a lecture entitled: “From theRead more »